[
    [
        {
            "time": "2021-08-05",
            "original_text": "欧普康视科技股份有限公司关于2021年...欧普康视公布半年报 上半年净利增加100.09%",
            "features": {
                "keywords": [
                    "欧普康视",
                    "中报业绩",
                    "净利润翻倍",
                    "角膜塑形镜",
                    "眼科医疗器械",
                    "终端布局",
                    "高增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "眼科"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "欧普康视科技股份有限公司关于2021年...欧普康视公布半年报 上半年净利增加100.09%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-08-05",
            "original_text": "安信证券维持欧普康视买入评级：中报业绩超预期，眼科医疗器械龙头如日中天，目标价111.11元",
            "features": {
                "keywords": [
                    "安信证券",
                    "买入评级",
                    "中报业绩",
                    "超预期",
                    "目标价"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "眼科"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "安信证券维持欧普康视买入评级：中报业绩超预期，眼科医疗器械龙头如日中天，目标价111.11元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-05",
            "original_text": "华金证券首予欧普康视增持评级：业绩符合预期，角膜塑形镜龙头扩产在即",
            "features": {
                "keywords": [
                    "华金证券",
                    "增持评级",
                    "角膜塑形镜",
                    "龙头扩产"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "眼科"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华金证券首予欧普康视增持评级：业绩符合预期，角膜塑形镜龙头扩产在即",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-05",
            "original_text": "光大证券：维持欧普康视“增持”评级 主营业务销量增加 业绩持续加速",
            "features": {
                "keywords": [
                    "光大证券",
                    "增持评级",
                    "主营业务",
                    "销量增加",
                    "业绩加速"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "眼科"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "光大证券：维持欧普康视“增持”评级 主营业务销量增加 业绩持续加速",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-05",
            "original_text": "欧普康视2021年半年报发布：上半年营业收入5.70亿元，同比增长91.94%",
            "features": {
                "keywords": [
                    "欧普康视",
                    "半年报",
                    "营业收入",
                    "同比增长"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "眼科"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "欧普康视2021年半年报发布：上半年营业收入5.70亿元，同比增长91.94%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]